| Stereochemistry | EPIMERIC |
| Molecular Formula | C20H28O6S.C4H11NO3 |
| Molecular Weight | 517.633 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 5 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(CO)(CO)CO.OC(COC1=CSC=C1)\C=C\[C@H]2[C@H](O)C[C@H](O)[C@@H]2C\C=C/CCCC(O)=O
InChI
InChIKey=ANXQNUUWCDBQFB-YXDKQNBXSA-N
InChI=1S/C20H28O6S.C4H11NO3/c21-14(12-26-15-9-10-27-13-15)7-8-17-16(18(22)11-19(17)23)5-3-1-2-4-6-20(24)25;5-4(1-6,2-7)3-8/h1,3,7-10,13-14,16-19,21-23H,2,4-6,11-12H2,(H,24,25);6-8H,1-3,5H2/b3-1-,8-7+;/t14?,16-,17-,18+,19-;/m1./s1
Tiaprost is a synthetic analog of prostaglandin F2α (PGF2α) patented by Hoechst A.-G. as an estrus-synchronizing agent for veterinary medicine. Tiaprost treatment reduced the interval from calving to conception in multiparous cows, but it delayed conception and reduced the conception rate in primiparous cows. Treatment with tiaprost impaired reproductive performance in primiparous cows
Originator
Approval Year
PubMed
Patents
ACTIVE MOIETY
SUBSTANCE RECORD
